Archive


Category: Andrew Bailey

  • GSK’s changes leave a long road ahead but CEO Walmsley deserves a hearing

    Emma Walmsley still has time to build belief in product pipeline – but clinging onto consumer division hardly shouts confidence “I am a change agent,” declared Emma Walmsley, as she unveiled the biggest overhaul of GlaxoSmithKline in the 20-odd years of the company’s life in its current form. The consumer healthcare division will depart via […]